Ligand-lytic peptides for specific targeting of Leishmania major and Trypanosoma cruzi parasites
Our results indicate that ligand-lytic peptide complexes are potential targets for therapeutic drugs that can selectively kill both extracellular and intracellular protozoa parasites stages with no significant toxicity to host cells.
Authors
- Claudia Husseneder (ORCID: https://orcid.org/0000-0001-5962-9354)
- Felipe Rodriguez (ORCID: https://orcid.org/0000-0003-1656-4989)
- Rosa A. Maldonado (ORCID: https://orcid.org/0000-0003-3180-7192)
- Eva Iniguez (ORCID: https://orcid.org/0009-0006-9027-0523)
- Lane D. Foil (ORCID: https://orcid.org/0009-0006-3284-033X)
Institutions
- Louisiana State University Agricultural Center (US)
- The University of Texas at El Paso (US)
- Border Network for Human Rights (US)
Publication Details
- Journal
- Frontiers in Cellular and Infection Microbiology
- Published
- 2025-05-30
- DOI
- https://doi.org/10.3389/fcimb.2025.1595333
- Primary Topic
- Research on Leishmaniasis Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Texas at El Paso
- Agricultural Center, Louisiana State University